Singer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama. 2016;315(8):801–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arvaniti V, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139(4):1246–56, 1256.e1-5.

Article  PubMed  Google Scholar 

Fernández J, et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut. 2018;67(10):1870–80.

Article  PubMed  Google Scholar 

Friedrich-Rust M, et al. Influence of antibiotic-regimens on intensive-care unit-mortality and liver-cirrhosis as risk factor. World J Gastroenterol. 2016;22(16):4201–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnston B, Butcher EC. Chemokines in rapid leukocyte adhesion triggering and migration. Semin Immunol. 2002;14(2):83–92.

Article  CAS  PubMed  Google Scholar 

Ono SJ, et al. Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol. 2003;111(6):1185–99 quiz 1200.

Article  CAS  PubMed  Google Scholar 

Olson TS, Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol. 2002;283(1):R7–28.

Article  CAS  PubMed  Google Scholar 

Cheng Y, et al. Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases. Biochim Biophys Acta Rev Cancer. 2019;1871(2):289–312.

Article  CAS  PubMed  Google Scholar 

Russo RC, et al. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases. Expert Rev Clin Immunol. 2014;10(5):593–619.

Article  CAS  PubMed  Google Scholar 

Sahin H, Trautwein C, Wasmuth HE. Functional role of chemokines in liver disease models. Nat Rev Gastroenterol Hepatol. 2010;7(12):682–90.

Article  CAS  PubMed  Google Scholar 

Sahin H, Berres ML, Wasmuth HE. Therapeutic potential of chemokine receptor antagonists for liver disease. Expert Rev Clin Pharmacol. 2011;4(4):503–13.

Article  CAS  PubMed  Google Scholar 

Chen K, et al. Chemokines in homeostasis and diseases. Cell Mol Immunol. 2018;15(4):324–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Sweringen HL, et al. Roles of hepatocyte and myeloid CXC chemokine receptor-2 in liver recovery and regeneration after ischemia/reperfusion in mice. Hepatology. 2013;57(1):331–8.

Article  PubMed  Google Scholar 

Emadi S, et al. IL-8 and its CXCR1 and CXCR2 receptors participate in the control of megakaryocytic proliferation, differentiation, and ploidy in myeloid metaplasia with myelofibrosis. Blood. 2005;105(2):464–73.

Article  CAS  PubMed  Google Scholar 

Kuboki S, et al. Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice. Hepatology. 2008;48(4):1213–23.

Article  CAS  PubMed  Google Scholar 

Ha H, Debnath B, Neamati N. Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases. Theranostics. 2017;7(6):1543–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stone MJ, et al. Mechanisms of regulation of the chemokine-receptor network. Int J Mol Sci. 2017;18(2):342.

Article  PubMed  PubMed Central  Google Scholar 

Albillos A, et al. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol. 2022;19(2):112–34.

Article  PubMed  Google Scholar 

Németh T, Sperandio M, Mócsai A. Neutrophils as emerging therapeutic targets. Nat Rev Drug Discov. 2020;19(4):253–75.

Article  PubMed  Google Scholar 

Khanam A, et al. Blockade of Neutrophil’s chemokine receptors CXCR1/2 abrogate liver damage in Acute-on-chronic liver failure. Front Immunol. 2017;8:464.

Article  PubMed  PubMed Central  Google Scholar 

Khanam A, Kottilil S. Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for Therapeutics. Front Immunol. 2020;11:2013.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X, et al. The role of CXCR2 in acute inflammatory responses and its antagonists as anti-inflammatory therapeutics. Curr Opin Hematol. 2019;26(1):28–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Konrad FM, Reutershan J. CXCR2 in acute lung injury. Mediators Inflamm. 2012;2012:740987.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12(2):121–7.

Article  CAS  PubMed  Google Scholar 

Raghuwanshi SK, et al. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions. J Immunol. 2012;189(6):2824–32.

Article  CAS  PubMed  Google Scholar 

Konishi T, et al. Cell-specific regulatory effects of CXCR2 on cholestatic liver injury. Am J Physiol Gastrointest Liver Physiol. 2019;317(6):G773-g783.

Article  PubMed  PubMed Central  Google Scholar 

Awaji M, et al. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Faseb j. 2020;34(7):9405–18.

Article  CAS  PubMed  Google Scholar 

Cataisson C, et al. Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis. Cancer Res. 2009;69(1):319–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dyer DP, et al. The chemokine receptor CXCR2 contributes to murine adipocyte development. J Leukoc Biol. 2019;105(3):497–506.

Article  CAS  PubMed  Google Scholar 

Goczalik I, et al. Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina. Invest Ophthalmol Vis Sci. 2008;49(10):4578–89.

Article  PubMed  Google Scholar 

Matsuo Y, et al. CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer. Int J Cancer. 2009;125(5):1027–37.

Article  CAS  PubMed  Google Scholar 

Wu F, et al. CXCR2 is essential for cerebral endothelial activation and leukocyte recruitment during neuroinflammation. J Neuroinflammation. 2015;12:98.

Article  PubMed  PubMed Central  Google Scholar 

Stefanovic L, Brenner DA, Stefanovic B. Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils. Exp Biol Med (Maywood). 2005;230(8):573–86.

Article  CAS  PubMed  Google Scholar 

Ren X, et al. Mitogenic properties of endogenous and pharmacological doses of macrophage inflammatory protein-2 after 70% hepatectomy in the mouse. Am J Pathol. 2003;163(2):563–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stefanovic L, Stefanovic B. Mechanism of direct hepatotoxic effect of KC chemokine: sequential activation of gene expression and progression from inflammation to necrosis. J Interferon Cytokine Res. 2006;26(10):760–70.

Article  CAS  PubMed  Google Scholar 

Wu Y, et al. Neutrophils lacking platelet-endothelial cell adhesion molecule-1 exhibit loss of directionality and motility in CXCR2-mediated chemotaxis. J Immunol. 2005;175(6):3484–91.

Article  CAS  PubMed  Google Scholar 

Ahuja SK, Murphy PM. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem. 1996;271(34):20545–50.

Article  CAS  PubMed  Google Scholar